Obs

Exp

SIR

95% CI

Obs

Exp

SIR

95% CI

Bladder, Urinary

Melanoma of Skin

Male

19

29.5

64.3

(38.7-100.5)

Male

22

14.8

149.1

(93.4-225.7)

Female

14

11.3

123.4

(67.4-207.1)

Female

21

12.3

170.4

(105.5-260.5)

Brain and Other Nervous System

Multiple Myeloma

Male

5

5.5

90.3

(29.1-210.7)

Male

2

4.1

nc

(nc-nc)

Female

2

5.1

nc

(nc-nc)

Female

1

3.5

nc

(nc-nc)

Breast

Non-Hodgkin Lymphoma

Male

0

0.9

nc

(nc-nc)

Male

14

14.6

96.0

(52.4-161.1)

Female

124

118.2

104.9

(87.3-125.1)

Female

11

14.0

78.6

(39.2-140.6)

Cervix Uteri

Oral Cavity & Pharynx

Male

10

11.4

87.8

(42.0-161.5)

Female

2

5.2

nc

(nc-nc)

Female

3

5.8

nc

(nc-nc)

Colon / Rectum

Ovary

Male

43

45.6

94.3

(68.2-127.0)

Female

34

46.2

73.6

(51.0-102.8)

Female

8

12.1

65.9

(28.4-129.9)

Esophagus

Pancreas

Male

7

7.2

96.6

(38.7-199.0)

Male

4

8.5

nc

(nc-nc)

Female

5

2.3

219.7

(70.8-512.8)

Female

9

9.6

93.9

(42.9-178.3)

Hodgkin Lymphoma

Prostate

Male

4

2.2

nc

(nc-nc)

Male

124

122.5

101.2

(84.2-120.7)

Female

1

2.3

nc

(nc-nc)

Kidney & Renal Pelvis

Stomach

Male

8

11.8

67.6

(29.1-133.2)

Male

3

7.8

nc

(nc-nc)

Female

10

8.1

123.8

(59.3-227.7)

Female

3

4.9

nc

(nc-nc)

Larynx

Testis

Male

1

5.4

nc

(nc-nc)

Male

0

3.3

nc

(nc-nc)

Female

2

1.5

nc

(nc-nc)

Leukemia

Thyroid

Male

9

9.0

100.4

(45.8-190.6)

Male

3

2.7

nc

(nc-nc)

Female

5

8.0

62.8

(20.2-146.5)

Female

6

9.2

65.4

(23.9-142.3)

Liver and Intrahepatic Bile Ducts

Uteri Corpus and Uterus, NOS

Male

4

5.5

nc

(nc-nc)

Female

2

2.2

nc

(nc-nc)

Female

20

23.5

85.0

(51.9-131.3)

Lung and Bronchus

All Sites / Types

Male

29

58.1

49.9

(33.4-71.7)

Male

326

395.9

82.3

(73.6-91.8)

Female

29

52.0

55.8

(37.4-80.2)

Female

337

385.5

87.4

(78.3-97.3)